搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rhizobium sp. Uncharacterized HTH-type transcriptional regulator y4mF (NGR_a02530) CSB-YP345882RKX
CSB-EP345882RKX
CSB-BP345882RKX
CSB-MP345882RKX
CSB-EP345882RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized ABC transporter ATP-binding protein y4mK (NGR_a02480) CSB-YP345883RKX
CSB-EP345883RKX
CSB-BP345883RKX
CSB-MP345883RKX
CSB-EP345883RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4nF (NGR_a02360) CSB-YP345884RKX
CSB-EP345884RKX
CSB-BP345884RKX
CSB-MP345884RKX
CSB-EP345884RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4nM (NGR_a02290), partial CSB-YP345885RKX
CSB-EP345885RKX
CSB-BP345885RKX
CSB-MP345885RKX
CSB-EP345885RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4oE (NGR_a02240) CSB-YP345886RKX
CSB-EP345886RKX
CSB-BP345886RKX
CSB-MP345886RKX
CSB-EP345886RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4oX (NGR_a02120) CSB-YP345887RKX
CSB-EP345887RKX
CSB-BP345887RKX
CSB-MP345887RKX
CSB-EP345887RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4pE/y4sA (NGR_a02070) CSB-YP345888RKX
CSB-EP345888RKX
CSB-BP345888RKX
CSB-MP345888RKX
CSB-EP345888RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Probable transposase for insertion sequence element ISRM3-like (NGR_a01970) CSB-YP345889RKX
CSB-EP345889RKX
CSB-BP345889RKX
CSB-MP345889RKX
CSB-EP345889RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4qD (NGR_a01940) CSB-YP345890RKX
CSB-EP345890RKX
CSB-BP345890RKX
CSB-MP345890RKX
CSB-EP345890RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4rG (NGR_a01800) CSB-YP345891RKX
CSB-EP345891RKX
CSB-BP345891RKX
CSB-MP345891RKX
CSB-EP345891RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4rO (NGR_a01720), partial CSB-YP345892RKX
CSB-EP345892RKX
CSB-BP345892RKX
CSB-MP345892RKX
CSB-EP345892RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized oxidoreductase y4sL (NGR_a01610) CSB-YP345893RKX
CSB-EP345893RKX
CSB-BP345893RKX
CSB-MP345893RKX
CSB-EP345893RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Probable amino-acid ABC transporter ATP-binding protein y4tH (NGR_a01510) CSB-YP345894RKX
CSB-EP345894RKX
CSB-BP345894RKX
CSB-MP345894RKX
CSB-EP345894RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4tN (NGR_a01450) CSB-YP345895RKX
CSB-EP345895RKX
CSB-BP345895RKX
CSB-MP345895RKX
CSB-EP345895RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. UPF0460 protein y4vQ (NGR_a01070) CSB-YP345896RKX
CSB-EP345896RKX
CSB-BP345896RKX
CSB-MP345896RKX
CSB-EP345896RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized transporter y4wD (NGR_a01010), partial CSB-YP345897RKX
CSB-EP345897RKX
CSB-BP345897RKX
CSB-MP345897RKX
CSB-EP345897RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4wJ (NGR_a00950) CSB-YP345898RKX
CSB-EP345898RKX
CSB-BP345898RKX
CSB-MP345898RKX
CSB-EP345898RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4xF (NGR_a00840) CSB-YP345899RKX
CSB-EP345899RKX
CSB-BP345899RKX
CSB-MP345899RKX
CSB-EP345899RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized MFS-type transporter y4xM (NGR_a00760), partial CSB-YP345900RKX
CSB-EP345900RKX
CSB-BP345900RKX
CSB-MP345900RKX
CSB-EP345900RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Nodulation protein nolU (nolU) CSB-YP345901RKX
CSB-EP345901RKX
CSB-BP345901RKX
CSB-MP345901RKX
CSB-EP345901RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>